IBD & Intestinal Disorders
From the AGA Journals
Biologics, thiopurines, or methotrexate doesn’t affect fertility or birth outcomes in men with IBD
This is the first meta-analysis to assess semen parameters and the risk of adverse outcomes in pregnancy for male patients with IBD who have taken...
From the Journals
Mirikizumab performs well in UC, new data show
Since 2014, the market size of interleukin inhibitors has grown fivefold with the greatest share belonging to IL-23 inhibitors.
Perspectives
Surveillance colonoscopy: When and how to stop
There is an ongoing debate about whether older adults should undergo CRC screening.
Latest News
No link between PPIs and dementia in new study
PPI use was not linked to changes in overall cognitive test scores over time.
From the AGA Journals
IBD study characterizes biologic adherence, confirms nonadherence risk factors
“Identifying patients at risk for nonadherence is important to develop strategies to improve adherence.”
Latest News
Medtronic to discontinue SmartPill capsule
A groundbreaking technology to pinpoint motility problems is being retired by its maker after 17 years on the market. Experts say there’s no easy...
From the AGA Journals
New AGA CPU focuses on gastric peroral endoscopic myotomy for gastroparesis
Clinical practice update authors suggest that G-POEM should be covered by health insurance.
From the AGA Journals
Race and ethnicity loom large in CRC screening
Disparities can be seen in everything from choice of test to bowel prep, according to a review.
Latest News
Etrasimod looks safe for ulcerative colitis out to 2.5 years
If approved by the FDA, etrasimod could become the second agent in the S1P class approved for ulcerative colitis in the United States.
From the AGA Journals
Upadacitinib shows promise in treatment-resistant UC and Crohn’s
A real-world study from a single clinical practice saw fast responses and high rates of remission, including among people previously treated with...